Melanoma Research Foundation/X
Jun 14, 2025, 18:25
We were excited to connect with the Conquer Cancer, the ASCO Foundation and Mark Schuiveling during ASCO25 – Melanoma Research Foundation
Melanoma Research Foundation shared a post on X:
“We were excited to connect with the Conquer Cancer, the ASCO Foundation and MRF Endowed Merit Awardee, Mark Schuiveling, from the University Medical Center in the Netherlands, during ASCO25!
Dr. Schuiveling joined us to share more on his research study titled “AI-detected tumor-infiltrating lymphocytes and response to PD-1 based treatment in advanced melanoma”.
Highlighting his work, he shares:
“Our study shows that having more immune cells in diagnostic metastatic melanoma biopsies, as detected by AI, may help predict response to immune checkpoint inhibition. While these results are promising, future research will focus on improving the accuracy of this prediction, with the ultimate goal of identifying patients most likely to benefit from immune checkpoint inhibition.”
We’re proud to support the next generation of melanoma researchers advancing successful treatments and patient care. Congratulations, Dr. Schuiveling on your well deserved award!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 14, 2025, 17:40
Jun 14, 2025, 16:32
Jun 14, 2025, 16:16